359 related articles for article (PubMed ID: 24618055)
1. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer.
Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsubota N; Tsujimura T; Tabata C; Nakano T; Hasegawa S
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):775-83. PubMed ID: 24618055
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients.
Okumura Y; Tanaka F; Yoneda K; Hashimoto M; Takuwa T; Kondo N; Hasegawa S
Ann Thorac Surg; 2009 Jun; 87(6):1669-75. PubMed ID: 19463575
[TBL] [Abstract][Full Text] [Related]
3. Early ligation of the pulmonary vein can reduce the dissemination of shed tumor cells during thoracoscopic lobectomy.
Duan X; Yang Z; Hao X; Zhou S; Liu Z; Zhang K; Cui Y
J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1623-1635.e2. PubMed ID: 35589423
[TBL] [Abstract][Full Text] [Related]
4. Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.
Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsujimura T; Nakano T; Hasegawa S
J Thorac Dis; 2018 Jan; 10(1):298-306. PubMed ID: 29600060
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study.
Duan X; Zhu Y; Cui Y; Yang Z; Zhou S; Han Y; Yu D; Xiao N; Cao X; Li Y; Liu S; Wang Z; Zhang W; Feng L; Zhang K; Shou J; Liu Z; Xu S
Thorac Cancer; 2019 Feb; 10(2):163-169. PubMed ID: 30511800
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
7. Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?
Sawabata N; Funaki S; Hyakutake T; Shintani Y; Fujiwara A; Okumura M
Surg Today; 2016 Dec; 46(12):1402-1409. PubMed ID: 26951195
[TBL] [Abstract][Full Text] [Related]
8. Significance of tumour vessel invasion in determining the morphology of isolated tumour cells in the pulmonary vein in non-small-cell lung cancer.
Funaki S; Sawabata N; Abulaiti A; Nakagiri T; Shintani Y; Inoue M; Minami M; Okumura M
Eur J Cardiothorac Surg; 2013 Jun; 43(6):1126-30. PubMed ID: 23100289
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer.
Tamminga M; de Wit S; van de Wauwer C; van den Bos H; Swennenhuis JF; Klinkenberg TJ; Hiltermann TJN; Andree KC; Spierings DCJ; Lansdorp PM; van den Berg A; Timens W; Terstappen LWMM; Groen HJM
Clin Cancer Res; 2020 Apr; 26(7):1656-1666. PubMed ID: 31772122
[TBL] [Abstract][Full Text] [Related]
10. Does the sequence of pulmonary vasculature ligation have any oncological impact during an anatomical lung resection for non-small-cell lung cancer?
Toufektzian L; Attia R; Polydorou N; Veres L
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):260-4. PubMed ID: 25355664
[TBL] [Abstract][Full Text] [Related]
11. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
Macchiarini P; Fontanini G; Hardin JM; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1992 Oct; 104(4):892-9. PubMed ID: 1328770
[TBL] [Abstract][Full Text] [Related]
12. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.
Ge MJ; Shi D; Wu QC; Wang M; Li LB
J Cancer Res Clin Oncol; 2006 Apr; 132(4):248-56. PubMed ID: 16320073
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer.
Okegawa T; Itaya N; Hara H; Tambo M; Nutahara K
Anticancer Res; 2014 Nov; 34(11):6705-10. PubMed ID: 25368278
[TBL] [Abstract][Full Text] [Related]
14. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.
Funaki S; Sawabata N; Nakagiri T; Shintani Y; Inoue M; Kadota Y; Minami M; Okumura M
Eur J Cardiothorac Surg; 2011 Aug; 40(2):322-7. PubMed ID: 21215651
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.
Peeters DJ; Brouwer A; Van den Eynden GG; Rutten A; Onstenk W; Sieuwerts AM; Van Laere SJ; Huget P; Pauwels P; Peeters M; Vermeulen PB; Dirix LY
Cancer Lett; 2015 Jan; 356(2 Pt B):872-9. PubMed ID: 25449778
[TBL] [Abstract][Full Text] [Related]
17. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.
Murlidhar V; Reddy RM; Fouladdel S; Zhao L; Ishikawa MK; Grabauskiene S; Zhang Z; Lin J; Chang AC; Carrott P; Lynch WR; Orringer MB; Kumar-Sinha C; Palanisamy N; Beer DG; Wicha MS; Ramnath N; Azizi E; Nagrath S
Cancer Res; 2017 Sep; 77(18):5194-5206. PubMed ID: 28716896
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
19. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
[TBL] [Abstract][Full Text] [Related]
20. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.
Lindsay CR; Blackhall FH; Carmel A; Fernandez-Gutierrez F; Gazzaniga P; Groen HJM; Hiltermann TJN; Krebs MG; Loges S; López-López R; Muinelo-Romay L; Pantel K; Priest L; Riethdorf S; Rossi E; Terstappen L; Wikman H; Soria JC; Farace F; Renehan A; Dive C; Besse B; Michiels S
Eur J Cancer; 2019 Aug; 117():60-68. PubMed ID: 31254940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
